Recent Finacing
Recent Raise
Gen2 Neuroscience discovers and develops drugs targeting toxic tau species using proprietary inducible stem-cell–derived human neurons from dementia patients to identify pathological tau and validate candidates.
Focus Areas
Recent Investors
Funding round
Investor